163 related articles for article (PubMed ID: 24990246)
21. High expression of TRAF4 predicts poor prognosis in tamoxifen-treated breast cancer and promotes tamoxifen resistance.
Zhou J; Li W; Ming J; Yang W; Lu L; Zhang Q; Ruan S; Huang T
Anticancer Drugs; 2020 Jul; 31(6):558-566. PubMed ID: 32304412
[TBL] [Abstract][Full Text] [Related]
22. Intracellular localization and transcriptional regulation of tumor necrosis factor (TNF) receptor-associated factor 4 (TRAF4).
Glauner H; Siegmund D; Motejadded H; Scheurich P; Henkler F; Janssen O; Wajant H
Eur J Biochem; 2002 Oct; 269(19):4819-29. PubMed ID: 12354113
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of Wnt signaling by cucurbitacin B in breast cancer cells: reduction of Wnt-associated proteins and reduced translocation of galectin-3-mediated β-catenin to the nucleus.
Dakeng S; Duangmano S; Jiratchariyakul W; U-Pratya Y; Bögler O; Patmasiriwat P
J Cell Biochem; 2012 Jan; 113(1):49-60. PubMed ID: 21866566
[TBL] [Abstract][Full Text] [Related]
24. WNT/β-catenin signaling inhibits CBP-mediated RelA acetylation and expression of proinflammatory NF-κB target genes.
Ma B; Fey M; Hottiger MO
J Cell Sci; 2015 Jul; 128(14):2430-6. PubMed ID: 26021349
[TBL] [Abstract][Full Text] [Related]
25. Loss of tumor suppressor Merlin results in aberrant activation of Wnt/β-catenin signaling in cancer.
Morrow KA; Das S; Meng E; Menezes ME; Bailey SK; Metge BJ; Buchsbaum DJ; Samant RS; Shevde LA
Oncotarget; 2016 Apr; 7(14):17991-8005. PubMed ID: 26908451
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-449b-5p suppresses the growth and invasion of breast cancer cells via inhibiting CREPT-mediated Wnt/β-catenin signaling.
Jiang J; Yang X; He X; Ma W; Wang J; Zhou Q; Li M; Yu S
Chem Biol Interact; 2019 Apr; 302():74-82. PubMed ID: 30738779
[TBL] [Abstract][Full Text] [Related]
27. Characterization of a beta-catenin nuclear localization defect in MCF-7 breast cancer cells.
Jamieson C; Mills KM; Lui C; Semaan C; Molloy MP; Sharma M; Forwood JK; Henderson BR
Exp Cell Res; 2016 Feb; 341(2):196-206. PubMed ID: 26844628
[TBL] [Abstract][Full Text] [Related]
28. JRK is a positive regulator of β-catenin transcriptional activity commonly overexpressed in colon, breast and ovarian cancer.
Pangon L; Ng I; Giry-Laterriere M; Currey N; Morgan A; Benthani F; Tran PN; Al-Sohaily S; Segelov E; Parker BL; Cowley MJ; Wright DC; St Heaps L; Carey L; Rooman I; Kohonen-Corish MR
Oncogene; 2016 Jun; 35(22):2834-41. PubMed ID: 26455321
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-374a activates Wnt/β-catenin signaling to promote breast cancer metastasis.
Cai J; Guan H; Fang L; Yang Y; Zhu X; Yuan J; Wu J; Li M
J Clin Invest; 2013 Feb; 123(2):566-79. PubMed ID: 23321667
[TBL] [Abstract][Full Text] [Related]
30. SOX9 regulates low density lipoprotein receptor-related protein 6 (LRP6) and T-cell factor 4 (TCF4) expression and Wnt/β-catenin activation in breast cancer.
Wang H; He L; Ma F; Regan MM; Balk SP; Richardson AL; Yuan X
J Biol Chem; 2013 Mar; 288(9):6478-87. PubMed ID: 23306204
[TBL] [Abstract][Full Text] [Related]
31. Biological functions and molecular interactions of Wnt/β-catenin in breast cancer: Revisiting signaling networks.
Hashemi M; Hasani S; Hajimazdarany S; Ghadyani F; Olyaee Y; Khodadadi M; Ziyarani MF; Dehghanpour A; Salehi H; Kakavand A; Goharrizi MASB; Aref AR; Salimimoghadam S; Akbari ME; Taheriazam A; Hushmandi K; Entezari M
Int J Biol Macromol; 2023 Mar; 232():123377. PubMed ID: 36702226
[TBL] [Abstract][Full Text] [Related]
32. Downregulated GBX2 gene suppresses proliferation, invasion and angiogenesis of breast cancer cells through inhibiting the Wnt/β-catenin signaling pathway.
Fang Y; Yuan Y; Zhang LL; Lu JW; Feng JF; Hu SN
Cancer Biomark; 2018; 23(3):405-418. PubMed ID: 30223390
[TBL] [Abstract][Full Text] [Related]
33. DACT2 is a functional tumor suppressor through inhibiting Wnt/β-catenin pathway and associated with poor survival in colon cancer.
Wang S; Dong Y; Zhang Y; Wang X; Xu L; Yang S; Li X; Dong H; Xu L; Su L; Ng SS; Chang Z; Sung JJ; Zhang X; Yu J
Oncogene; 2015 May; 34(20):2575-85. PubMed ID: 25023701
[TBL] [Abstract][Full Text] [Related]
34. [Nuclear beta-catenin localization is not sufficient for canonical Wnt signaling activation in human meianoma cell lines].
Kulikova KV; Posviatenko AV; Gnuchev NV; Georgiev GP; Kibardin AV; Larin SS
Mol Biol (Mosk); 2011; 45(5):884-91. PubMed ID: 22393786
[TBL] [Abstract][Full Text] [Related]
35. PLA2G7/PAF-AH as Potential Negative Regulator of the Wnt Signaling Pathway Mediates Protective Effects in BRCA1 Mutant Breast Cancer.
Liao Y; Badmann S; Kraus F; Topalov NE; Mayr D; Kolben T; Hester A; Beyer S; Mahner S; Jeschke U; Trillsch F; Czogalla B; Burges A
Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614323
[TBL] [Abstract][Full Text] [Related]
36. The dietary terpene lupeol targets colorectal cancer cells with constitutively active Wnt/β-catenin signaling.
Tarapore RS; Siddiqui IA; Adhami VM; Spiegelman VS; Mukhtar H
Mol Nutr Food Res; 2013 Nov; 57(11):1950-8. PubMed ID: 23836602
[TBL] [Abstract][Full Text] [Related]
37. β-catenin deacetylation is essential for WNT-induced proliferation of breast cancer cells.
Wang SH; Li N; Wei Y; Li QR; Yu ZP
Mol Med Rep; 2014 Mar; 9(3):973-8. PubMed ID: 24401947
[TBL] [Abstract][Full Text] [Related]
38. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.
Tsai JH; Hsu LS; Lin CL; Hong HM; Pan MH; Way TD; Chen WJ
Toxicol Appl Pharmacol; 2013 Nov; 272(3):746-56. PubMed ID: 23921149
[TBL] [Abstract][Full Text] [Related]
39. Expression, correlation, and prognostic value of TRAF2 and TRAF4 expression in malignant plural effusion cells in human breast cancer.
Zhao ZJ; Ren HY; Yang F; Wang J; Wu GP; Mi XY
Diagn Cytopathol; 2015 Nov; 43(11):897-903. PubMed ID: 26331901
[TBL] [Abstract][Full Text] [Related]
40. TRAF4-mediated ubiquitination of NGF receptor TrkA regulates prostate cancer metastasis.
Singh R; Karri D; Shen H; Shao J; Dasgupta S; Huang S; Edwards DP; Ittmann MM; O'Malley BW; Yi P
J Clin Invest; 2018 Jul; 128(7):3129-3143. PubMed ID: 29715200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
